Anaheim Bio - California News Beep

November 5, 2026

Anaheim Bio, a Leiden, Netherlands-based biotechnology company developing treatments for calcium pyrophosphate deposition disease (CPPD), has launched with…

AAnaheim

Anaheim Bio Raises €40M in Series A Funding

November 5, 2026

Anaheim Bio, a Leiden, the Netherlands-based preclinical-stage biotechnology company, raised €40M in Series A funding. Backers included Droia Ventures, Frazier Life Sciences, RTW…

AAnaheim

Anaheim Bio Launches with €40 Million Series A Financing to Advance ANA-1 for Calcium Pyrophosphate Deposition Disease into the Clinic

November 5, 2026

Anaheim spun out of Alesta Therapeutics prior to its recent acquisition by BioMarin Financing provided by Droia Ventures,…